T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

被引：0
|
作者：
K Mihara
J Bhattacharyya
A Kitanaka
K Yanagihara
T Kubo
Y Takei
H Asaoku
Y Takihara
A Kimura
机构：
[1] Research Institute for Radiation Biology and Medicine,Department of Hematology and Oncology
[2] Hiroshima University,Department of Laboratory Medicine
[3] Faculty of Medicine,Department of Life Science
[4] Kagawa University,Department of Biochemistry
[5] Yasuda Women’s University Faculty of Pharmacy,Department of Clinical Laboratory
[6] Nagoya University Graduate School of Medicine,Department of Stem Cell Biology
[7] Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital,undefined
[8] Research Institute for Radiation Biology and Medicine,undefined
[9] Hiroshima University,undefined
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：365 / 367
页数：2
相关论文
共 50 条
  • [21] Dar-ting at CD38 in T-cell leukemias
    Senapati, Jayastu
    Jabbour, Elias
    BLOOD, 2024, 144 (21)
  • [22] EVALUATION OF CD38 AS TARGET FOR IMMUNOTHERAPY IN MULTIPLE-MYELOMA
    VOOIJS, WC
    SCHUURMAN, HJ
    BAST, EJEG
    DEGAST, GC
    BLOOD, 1995, 85 (08) : 2282 - 2283
  • [23] Pathobiology and Targeting of CD38 in Cutaneous T-Cell Lymphoma
    Isabelle, Colleen
    Boles, Amy
    McConnell, Kathleen
    Keller, Robyn
    Cheslow, Lara
    Xu, Jonathan
    Waldman, Scott
    Chakravarti, Nitin
    Porcu, Pierluigi
    Nikbakht, Neda
    Mishra, Anjali
    BLOOD, 2023, 142
  • [24] Evaluation of CD38 Expression in T-cell Lymphoproliferative Disorders
    Grant, Michelle L.
    Lunde, John H.
    Devitt, Katherine A.
    Gardner, Juli-Anne
    MODERN PATHOLOGY, 2017, 30 : 352A - 352A
  • [25] Towards Effective Immunotherapy of Multiple Myeloma: Enhanced Elimination of Myeloma Cells by Combination of Lenalidomide with the Human CD38 Monoclonal Antibody Daratumumab
    van der Veer, Michael S.
    de Weers, Michel
    van Kessel, Berris
    Wittebol, Shulamiet
    Bakker, Joost M.
    Parren, Paul W. H. I.
    Lokhorst, Henk M.
    Mutis, Tuna
    BLOOD, 2010, 116 (21) : 1262 - 1262
  • [26] Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies
    Png, Yi Tian
    Vinanica, Natasha
    Kamiya, Takahiro
    Shimasaki, Noriko
    Coustan-Smith, Elaine
    Campana, Dario
    BLOOD ADVANCES, 2017, 1 (25) : 2348 - 2360
  • [27] Functional associations of CD38 with CD3 on the T-cell membrane
    Reinis, M
    Morra, M
    Funaro, A
    Di Primio, R
    Malavasi, F
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1997, 11 (04): : 137 - 142
  • [28] Chimeric antigen receptor T-cell therapies for multiple myeloma
    Mikkilineni, Lekha
    Kochenderfer, James N.
    BLOOD, 2017, 130 (24) : 2594 - 2602
  • [29] Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
    Hosen, Naoki
    CANCERS, 2019, 11 (12)
  • [30] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Wang, Zehua
    Chen, Chen
    Wang, Lei
    Jia, Yongxu
    Qin, Yanru
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345